Lv1
40 积分 2024-04-17 加入
Two-year outcomes of clinical N2-3 esophageal squamous cell carcinoma after neoadjuvant chemotherapy and immunotherapy from the phase 2 NICE study
19天前
已完结
The Growth of Screening-Detected Pure Ground-Glass Nodules Following 10 Years of Stability
1个月前
已完结
Comparison of 10-year Survival Outcomes between CT Surveillance and Surgery for Ground-Glass Nodules
1个月前
已完结
Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial
5个月前
已完结
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study
5个月前
已完结
Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer
5个月前
已完结
Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer
7个月前
已完结
Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC
7个月前
已完结
Is Sublobar Resection Feasible for High-Risk Pathologic Stage I Non-small Cell Lung Cancer?
8个月前
已完结
Generalization after ocular onset in myasthenia gravis: a case series in Germany
8个月前
已完结
皖公网安备34019202002308
